Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protocadherin gamma subfamily A, 7 (PCDHGA7) is a membrane-bound, calcium-dependent cell-adhesion protein encoded by the PCDHGA7 gene. It belongs to the gamma cluster of the protocadherin family, characterized by an immunoglobulin-like organization and clustered gene locus on chromosome 5. The protein is predicted to play a pivotal role in mediating and maintaining specific cell-cell connections in the brain, particularly in neural circuitry development. In the epidermis, PCDHGA7 helps maintain structural integrity among basal keratinocytes. Diseases associated with mutations in PCDHGA7 include certain neurodevelopmental disorders and Cenani-Lenz syndactyly syndrome. The exact physiological functions in humans, especially in pathological contexts, remain under investigation. There are currently no therapeutically approved drugs targeting PCDHGA7, and it is not considered a conventional drug target
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protocadherin gamma subfamily A, 7 (PCDHGA7).